Company Filing History:
1 out of 2 
1 out of 832,761 Years Active: 1993-1997
Title: Innovations of Jeffrey T Davis
Introduction
Jeffrey T Davis is an accomplished inventor based in Watertown, MA (US). He holds two patents that showcase his expertise in the field of oligosaccharide chemistry. His innovative work has the potential to significantly impact the biological and physiochemical properties of proteins.
Latest Patents
Davis's latest patents focus on the production of oligosaccharide oxazolines and conjugates. One notable invention relates to a method of producing peracetyloxazolines from peracetyl saccharides. This method involves reacting a peracetyl saccharide with a specific reagent combination to directly produce the peracetyl oxazoline. The process can activate oligosaccharides, particularly those containing a reducing GlcNAc terminus, by forming an oxazolide at the terminal GlcNAc. This activated oligosaccharide can then be coupled with a bifunctional spacer to create an oligosaccharide-spacer conjugate. Ultimately, this conjugate can be linked to proteins, such as granulocyte colony-stimulating factor or gamma-interferon, resulting in a neoglycoprotein conjugate. This invention aims to enhance the serum lifetime and efficiency of drug delivery to target organs or cells.
Career Highlights
Throughout his career, Jeffrey T Davis has made significant contributions to the field of biochemistry. He has worked with notable companies, including Genzyme Corporation, where he applied his innovative ideas to real-world applications. His work has been instrumental in advancing the understanding and utilization of oligosaccharides in therapeutic contexts.
Collaborations
Davis has collaborated with esteemed colleagues, including Marcelo Colon and James R Rasmussen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking innovations.
Conclusion
Jeffrey T Davis is a notable inventor whose work in oligosaccharide chemistry has the potential to revolutionize drug delivery systems. His patents reflect a deep understanding of biochemical processes and a commitment to improving therapeutic outcomes.